|
DK365785A
(da)
*
|
1984-09-17 |
1986-03-18 |
Hoffmann La Roche |
Metalcomplexer
|
|
US5075447A
(en)
*
|
1984-09-17 |
1991-12-24 |
Hoffmann-La Roche Inc. |
Ruthenium complexes useful as carriers for immunologically active materials
|
|
GB8601646D0
(en)
|
1986-01-23 |
1986-02-26 |
Davidson R S |
Binding assay & reagent
|
|
US5585279A
(en)
*
|
1986-01-23 |
1996-12-17 |
Davidson; Robert S. |
Time-resolved luminescence binding assays using a fluorescent transition metal label other than ruthenium
|
|
US6018030A
(en)
*
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
MX9203454A
(es)
|
1989-12-28 |
1992-08-01 |
Upjohn Co |
Compuestos anti sida diaromaticos substituidos.
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US5708022A
(en)
*
|
1994-10-28 |
1998-01-13 |
Procept, Inc. |
Method for inhibiting immune response
|
|
AU4017695A
(en)
|
1994-10-28 |
1996-05-23 |
Procept, Inc. |
Ruthenium complexes and their use as immunosuppressive agents
|
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
|
US5831003A
(en)
|
1996-06-28 |
1998-11-03 |
Bayer Corporation |
Peptides which bind to prothrombin and thrombin
|
|
JP2002511934A
(ja)
|
1997-06-18 |
2002-04-16 |
ウルリッヒ・ジェイ・クルール |
核酸バイオセンサ診断装置
|
|
AU1824899A
(en)
|
1997-12-15 |
1999-07-05 |
Joseph R Lakowicz |
Method and composition for characterizing a sample containing a sample lipid andan assay kit
|
|
US6759243B2
(en)
*
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
|
US6472367B1
(en)
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
|
ES2299244T3
(es)
*
|
1998-05-13 |
2008-05-16 |
Domantis Limited |
Sistema de exposicion de fagos para la seleccion de proteinas correctamente plegadas.
|
|
JP2002514400A
(ja)
*
|
1998-05-13 |
2002-05-21 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
遍在的に発現される新規な遺伝子のリバースストランドによってコードされている腫瘍関連抗原
|
|
US7037667B1
(en)
*
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
|
US7521197B2
(en)
*
|
1998-06-05 |
2009-04-21 |
Alexis Biotech Limited |
Method for producing cytotoxic T-cells
|
|
US20020106678A1
(en)
|
1998-06-30 |
2002-08-08 |
Robishaw Janet D. |
cDNA clones encoding human G protein gamma subunits
|
|
EP1090012A4
(en)
|
1998-07-02 |
2005-04-06 |
Merck & Co Inc |
INHIBITORS OF PRENYL-PROTEIN TRANSFERASE
|
|
US6288221B1
(en)
*
|
1998-08-20 |
2001-09-11 |
Duke University |
Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction
|
|
AU6136599A
(en)
|
1998-09-08 |
2000-03-27 |
University Of Maryland At Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
|
US6806089B1
(en)
*
|
1998-09-08 |
2004-10-19 |
University Of Maryland, Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
|
JP4780834B2
(ja)
*
|
1998-10-22 |
2011-09-28 |
フィリップ・ビー・ビー・モヘノ |
新規なプテリン抗新生物薬
|
|
CA2367282A1
(en)
*
|
1999-03-19 |
2000-09-28 |
Simon Fricker |
Pharmaceutical compositions comprising metal complexes
|
|
US6872519B1
(en)
*
|
1999-04-27 |
2005-03-29 |
Mirus Bio Corporation |
In vitro process for selecting phage resistant to blood inactivation
|
|
US20090087878A9
(en)
*
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
US20030024579A1
(en)
|
1999-07-07 |
2003-02-06 |
Blackmore Donald Ian |
Diverter valve
|
|
GB9916529D0
(en)
*
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
|
AU781880B2
(en)
|
1999-09-17 |
2005-06-16 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
WO2001046209A1
(en)
|
1999-12-20 |
2001-06-28 |
Fluorrx, Inc. |
Fluorescent probes
|
|
US20030219806A1
(en)
*
|
2000-02-22 |
2003-11-27 |
Millennium Pharmaceuticals, Inc. |
Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
|
|
US7585839B2
(en)
*
|
2000-02-23 |
2009-09-08 |
Zealand Pharma A/S |
Medical uses of intercellular communication facilitating compounds
|
|
US20030215860A1
(en)
*
|
2000-02-29 |
2003-11-20 |
Millennium Pharmaceuticals, Inc. |
Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
|
|
AU4592601A
(en)
*
|
2000-03-21 |
2001-10-03 |
Millennium Predictive Medicine |
Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
|
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
US7834146B2
(en)
*
|
2000-05-08 |
2010-11-16 |
Monsanto Technology Llc |
Recombinant polypeptides associated with plants
|
|
CA2411971A1
(en)
*
|
2000-06-16 |
2001-12-27 |
Incyte Genomics, Inc. |
Proteases
|
|
WO2002006339A2
(en)
*
|
2000-07-03 |
2002-01-24 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
US20050053930A1
(en)
*
|
2000-07-18 |
2005-03-10 |
David Anderson |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US6812339B1
(en)
*
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
US7264810B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
TWI329129B
(en)
*
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
|
US6783969B1
(en)
*
|
2001-03-05 |
2004-08-31 |
Nuvelo, Inc. |
Cathepsin V-like polypeptides
|
|
US7030236B2
(en)
|
2001-03-09 |
2006-04-18 |
Mona Savitri Jhaveri |
Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof
|
|
WO2002071928A2
(en)
|
2001-03-14 |
2002-09-19 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
US20030065157A1
(en)
|
2001-04-04 |
2003-04-03 |
Lasek Amy W. |
Genes expressed in lung cancer
|
|
EP1573024A4
(en)
*
|
2001-04-10 |
2007-08-29 |
Agensys Inc |
NUCLEIC ACIDS AND SUITABLE PROTEINS SUITABLE FOR THE TREATMENT AND EVIDENCE OF VARIOUS CANCER DISEASES
|
|
CA2444691A1
(en)
*
|
2001-04-18 |
2002-10-31 |
Protein Design Labs, Inc. |
Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
|
|
MXPA03011979A
(es)
*
|
2001-06-18 |
2005-04-08 |
Eos Biotechnology Inc |
Metodos de diagnostico de cancer de ovario composiciones y metodos para rastrear moduladores de cancer de ovario.
|
|
US20040053824A1
(en)
*
|
2001-06-29 |
2004-03-18 |
Tang Y Tom |
Extracellular matrix and cell adhesion molecules
|
|
US20030099974A1
(en)
|
2001-07-18 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
ES2373644T3
(es)
|
2001-08-31 |
2012-02-07 |
Btg International Limited |
Uso de derivados de ciclopenta[g]quinazolina para el tratamiento del c�?ncer.
|
|
KR100983962B1
(ko)
|
2001-08-31 |
2010-09-27 |
비티지 인터내셔널 리미티드 |
항암제로서 사용되는 시클로펜타[ｇ]퀴나졸린 화합물
|
|
US7622260B2
(en)
|
2001-09-05 |
2009-11-24 |
The Brigham And Women's Hospital, Inc. |
Diagnostic and prognostic tests
|
|
US20030124579A1
(en)
|
2001-09-05 |
2003-07-03 |
Eos Biotechnology, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
|
AR045702A1
(es)
*
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
|
BR0214295A
(pt)
|
2001-11-19 |
2004-11-09 |
Elan Pharm Inc |
Composto, método para tratar um paciente que tem ou prevenir um paciente de adquirir uma doença ou condição, e, método para produzir um composto
|
|
DE10162480A1
(de)
*
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
US7635681B2
(en)
*
|
2002-01-09 |
2009-12-22 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US8048408B2
(en)
*
|
2002-01-16 |
2011-11-01 |
Biocompatibles Uk Limited |
Polymer conjugates
|
|
ES2426420T3
(es)
*
|
2002-01-28 |
2013-10-23 |
Keraplast Technologies Ltd. |
Péptidos de queratina bioactivos
|
|
US6962910B2
(en)
*
|
2002-02-01 |
2005-11-08 |
Virginia Tech Intellectual Properties, Inc. |
Supramolecular complexes as photoactivated DNA cleavage agents
|
|
US20050095592A1
(en)
|
2002-02-13 |
2005-05-05 |
Jazaeri Amir A. |
Identification of ovarian cancer tumor markers and therapeutic targets
|
|
DE10206616A1
(de)
*
|
2002-02-15 |
2003-09-04 |
Qiagen Gmbh |
Verfahren zur Reduktion der Background-Kontamination nach Markierungsreaktionen
|
|
US20040009939A1
(en)
*
|
2002-03-05 |
2004-01-15 |
Board Of Regent, The University Of Texas System |
Methods of enhancing immune induction involving MDA-7
|
|
WO2003087768A2
(en)
*
|
2002-04-12 |
2003-10-23 |
Mitokor |
Targets for therapeutic intervention identified in the mitochondrial proteome
|
|
WO2003099205A2
(en)
*
|
2002-05-20 |
2003-12-04 |
Abgenix, Inc. |
Treatment of renal carcinoma using antibodies against the egfr
|
|
CA2500687A1
(en)
*
|
2002-10-02 |
2004-04-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP1422242A1
(en)
|
2002-11-22 |
2004-05-26 |
Emory University |
Plastic and elastic protein copolymers
|
|
KR20050115231A
(ko)
*
|
2003-02-10 |
2005-12-07 |
내셔날 인스티튜트 오브 어드밴스드 인더스트리얼 사이언스 앤드 테크놀로지 |
포유동물 세포의 조절
|
|
WO2004087874A2
(en)
|
2003-03-28 |
2004-10-14 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
EP1635866A2
(en)
*
|
2003-05-20 |
2006-03-22 |
Cellpep S.A. |
Modified antiviral peptides with increased activity and cell membrane affinity
|
|
CA2526393A1
(en)
*
|
2003-05-21 |
2004-12-02 |
Genesense Technologies Inc. |
Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer
|
|
US20060078941A1
(en)
|
2003-06-09 |
2006-04-13 |
Santin Alessandro D |
Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
|
|
GB0314472D0
(en)
|
2003-06-20 |
2003-07-23 |
Warwick Effect Polymers Ltd |
Polymer
|
|
GB0318096D0
(en)
*
|
2003-08-01 |
2003-09-03 |
Queen Mary & Westfield College |
Vaccine
|
|
DE10335833A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
US20050147621A1
(en)
*
|
2003-10-10 |
2005-07-07 |
Higgins Darren E. |
Use of bacterial 5' untranslated regions for nucleic acid expression
|
|
DE10347710B4
(de)
*
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
JP2007514648A
(ja)
*
|
2003-10-24 |
2007-06-07 |
エーザイ株式会社 |
Ｔｏｌｌ−ｌｉｋｅｒｅｃｅｐｔｏｒ２に関連する疾患及び状態を治療するための化合物及び方法
|
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
|
EP1547581A1
(en)
|
2003-12-23 |
2005-06-29 |
Vectron Therapeutics AG |
Liposomal vaccine for the treatment of human hematological malignancies
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
WO2005066337A2
(en)
*
|
2004-01-09 |
2005-07-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
|
|
AU2005213464A1
(en)
|
2004-02-06 |
2005-08-25 |
Wyeth |
Diagnosis and therapeutics for cancer
|
|
EP1723428A2
(en)
|
2004-02-19 |
2006-11-22 |
Yale University Corporation |
Identification of cancer protein biomarkers using proteomic techniques
|
|
KR20070007128A
(ko)
|
2004-03-01 |
2007-01-12 |
펩테라 파마슈티컬스 엘티디. |
카제인 파생 펩타이드들과 그의 치료적 사용들
|
|
JP5017107B2
(ja)
|
2004-07-06 |
2012-09-05 |
ワーウィック イフェクト ポリマーズ リミテッド |
ポリペプチド等と反応し得る官能基を含むリビングラジカル重合開始剤、それを用いて得られる櫛形ポリマー、それから得られるポリペプチド複合体及び薬剤
|
|
WO2007084413A2
(en)
|
2004-07-14 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7772271B2
(en)
*
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7553944B2
(en)
*
|
2004-07-21 |
2009-06-30 |
The University Of Hong Kong |
Human virus causing respiratory tract infection and uses thereof
|
|
US20080280317A1
(en)
*
|
2004-08-27 |
2008-11-13 |
Northeastern University |
Comprehensive Characterization Of Complex Proteins At Trace Levels
|
|
DE102004042546A1
(de)
*
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
|
JP2008512490A
(ja)
|
2004-09-08 |
2008-04-24 |
チェルシー・セラピューティクス，インコーポレイテッド |
異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤
|
|
WO2006044335A2
(en)
|
2004-10-14 |
2006-04-27 |
The Board Of Trustees Of The University Of Arkansas |
Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
|
|
EP1814573B1
(en)
*
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
AU2005323062A1
(en)
*
|
2005-01-04 |
2006-07-13 |
The Brigham And Women's Hospital, Inc. |
Sustained delivery of PDGF using self-assembling peptide nanofibers
|
|
CA2596003C
(en)
|
2005-01-27 |
2012-12-18 |
Asahi Kasei Pharma Corporation |
Six-membered heterocyclic compound and use thereof
|
|
US7531533B2
(en)
*
|
2005-01-27 |
2009-05-12 |
Asahi Kasei Pharma Corporation |
6-Membered heterocyclic compound and use thereof
|
|
NZ597997A
(en)
*
|
2005-02-14 |
2013-10-25 |
Epitopix Llc |
Antibody compositions that bind polypeptides from staphylococcus aureus
|
|
CA2598889A1
(en)
*
|
2005-02-24 |
2006-08-31 |
Cemines, Inc. |
Compositions and methods for classifying biological samples
|
|
CN101189229A
(zh)
|
2005-03-17 |
2008-05-28 |
哈佛大学校长及研究员协会 |
阿韦艾利酰胺、斯特伐希丁b和其类似物的合成
|
|
FR2885525B1
(fr)
*
|
2005-05-13 |
2009-09-18 |
Urodelia Sa |
Medicament notamment anti-cancereux, destine a des traitements par immunotherapie, en particulier autologue
|
|
US8008260B2
(en)
*
|
2005-06-13 |
2011-08-30 |
Cleveland Clinic Foundation |
Methods of protecting against apoptosis using lipopeptides
|
|
WO2006138380A2
(en)
|
2005-06-15 |
2006-12-28 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
KR101363278B1
(ko)
|
2005-06-27 |
2014-02-21 |
엑셀리시스 페이턴트 컴퍼니 엘엘씨 |
이미다졸계 ｌｘｒ 변조제
|
|
WO2007005249A2
(en)
|
2005-06-29 |
2007-01-11 |
Hyperbranch Medical Technology, Inc. |
Nanoparticles and dendritic-polymer-based hydrogels comprising them
|
|
US7494788B2
(en)
*
|
2005-07-11 |
2009-02-24 |
Molecular Kinetics, Inc. |
Entropic bristle domain sequences and their use in recombinant protein production
|
|
US7820790B2
(en)
*
|
2005-07-13 |
2010-10-26 |
Amgen Mountain View Inc. |
IL-6 binding proteins
|
|
GB0516058D0
(en)
|
2005-08-04 |
2005-09-14 |
Oxford Genome Sciences Uk Ltd |
New protein isoforms and uses thereof
|
|
GB0517293D0
(en)
|
2005-08-24 |
2005-10-05 |
Cancer Rec Tech Ltd |
Vectors and uses thereof
|
|
EP2228656B1
(en)
*
|
2005-09-15 |
2013-10-23 |
Alk-Abelló A/S |
Quantification of allergens
|
|
WO2007073432A2
(en)
|
2005-10-11 |
2007-06-28 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
|
AU2006303037A1
(en)
|
2005-10-21 |
2007-04-26 |
Merz Pharma Gmbh & Co Kgaa |
Chromenones and their use as modulators of metabotropic glutamate receptors
|
|
UA96139C2
(uk)
*
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
|
ATE486875T1
(de)
|
2005-11-10 |
2010-11-15 |
Chemocentryx Inc |
Substituierte chinolone und verwendungsverfahren
|
|
WO2007061853A2
(en)
|
2005-11-23 |
2007-05-31 |
Merck & Co., Inc. |
Process for synthesizing 2-phenyl-1h-phenantrho[9,10-d]imidazole derivative
|
|
KR101049859B1
(ko)
|
2007-11-28 |
2011-07-19 |
대한민국 |
Ｎ-말단 ｐＩ 값 조절에 의한 수용성 재조합 단백질 생산방법
|
|
US20100040606A1
(en)
*
|
2006-03-06 |
2010-02-18 |
Symphogen A/S |
Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
|
|
JP5167155B2
(ja)
|
2006-03-09 |
2013-03-21 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
ペプチド結合に基づく多数の細胞株のプロファイリングに関連した組成物および方法
|
|
MX2008011584A
(es)
|
2006-03-10 |
2008-12-12 |
Warwick Effect Polymers Ltd |
Polimeros.
|
|
WO2007110755A1
(en)
|
2006-03-27 |
2007-10-04 |
Medical Therapies Limited |
Prophylaxis or treatment of cardiovascular inflammation
|
|
JP5093783B2
(ja)
*
|
2006-04-20 |
2012-12-12 |
クリングルファーマ株式会社 |
Ｈｇｆ前駆体蛋白質改変体及びその活性型蛋白質
|
|
WO2007131191A2
(en)
*
|
2006-05-05 |
2007-11-15 |
Perkinelmer Life And Analytical Sciences |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
|
EP2348106B1
(en)
|
2006-05-08 |
2014-07-02 |
Adaerata, Limited Partnership |
Chimeric proteins, cells comprising same, and assays using same
|
|
CA2655933C
(en)
*
|
2006-06-23 |
2014-09-09 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in cancer
|
|
NL1032064C2
(nl)
*
|
2006-06-27 |
2008-01-02 |
Walraven Holding Bv J Van |
Pijpbeugel met trillingisolerende inlaag.
|
|
US20090297401A1
(en)
*
|
2006-06-28 |
2009-12-03 |
Rgb Technologies Ab |
Sensor kit and a system for detecting an analyte in a test environment
|
|
US8198046B2
(en)
*
|
2006-07-11 |
2012-06-12 |
Danisco Us Inc. |
KEX2 cleavage regions of recombinant fusion proteins
|
|
CN101516388B
(zh)
*
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
|
WO2008012362A2
(en)
*
|
2006-07-27 |
2008-01-31 |
Oxford Genome Sciences (Uk) Ltd |
New protein isoforms and uses thereof
|
|
EP2052088A2
(en)
*
|
2006-08-02 |
2009-04-29 |
Genizon Biosciences |
Genemap of the human genes associated with psoriasis
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
WO2008029031A2
(fr)
*
|
2006-09-07 |
2008-03-13 |
Laurence Faure |
Test pharmaco diagnostique ciblant l' oncologie
|
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
|
EP2094715B1
(en)
|
2006-10-30 |
2012-08-29 |
Sanrx Pharmaceuticals, Inc. |
Dipterinyl calcium pentahydrate (dcp) and therapeutic methods based thereon
|
|
DE102006051516A1
(de)
*
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
MX2009007053A
(es)
|
2006-12-28 |
2009-07-09 |
Abbott Lab |
Inhibidores de poli (adp-ribosa) polimerasa.
|
|
KR101493474B1
(ko)
*
|
2007-01-09 |
2015-02-16 |
클리브랜드 바이오랩스, 아이엔씨. |
조혈 줄기 세포를 증가시키고 이동시키는 방법들
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
WO2008124483A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Specigen, Inc. |
Protein cage immunotherapeutics
|
|
US20080306007A1
(en)
*
|
2007-04-30 |
2008-12-11 |
Newcastle Innovation Limited |
Agents for prophylaxis or treatment of neurological related diseases and conditions
|
|
US20090110662A1
(en)
*
|
2007-04-30 |
2009-04-30 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
US8143372B2
(en)
*
|
2007-05-21 |
2012-03-27 |
Children's Hospital & Research Center Oakland |
Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
|
|
US20090176664A1
(en)
*
|
2007-06-01 |
2009-07-09 |
Keting Chu |
High density peptide arrays containing kinase or phosphatase substrates
|
|
US8618121B2
(en)
|
2007-07-02 |
2013-12-31 |
Cancer Research Technology Limited |
9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
|
|
US9018138B2
(en)
*
|
2007-08-16 |
2015-04-28 |
The Johns Hopkins University |
Compositions and methods for generating and screening adenoviral libraries
|
|
AU2008295248A1
(en)
*
|
2007-09-07 |
2009-03-12 |
Symphogen A/S |
Methods for recombinant manufacturing of anti-RSV antibodies
|
|
GB0719644D0
(en)
|
2007-10-05 |
2007-11-14 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
WO2009061681A2
(en)
|
2007-11-06 |
2009-05-14 |
Amira Pharmaceuticals, Inc |
Antagonists of pgd2 receptors
|
|
WO2009111088A2
(en)
|
2008-01-02 |
2009-09-11 |
The Johns Hopkins University |
Antitumor immunization by liposomal delivery of vaccine to the spleen
|
|
WO2009114942A1
(en)
|
2008-03-20 |
2009-09-24 |
University Health Network |
Thymidylate kinase fusions and uses thereof
|
|
CA2723824C
(en)
*
|
2008-05-09 |
2022-12-06 |
Surmodics Pharmaceuticals, Inc. |
Biocompatible and biodegradable elastomeric polymers
|
|
EP2306993B1
(en)
|
2008-05-26 |
2014-03-12 |
Universität Zürich |
Protamine/rna nanoparticles for immunostimulation
|
|
MX2010014172A
(es)
|
2008-07-03 |
2011-02-22 |
Amira Pharmaceuticals Inc |
Antagonistas de receptores de prostaglandina d2.
|
|
US8148088B2
(en)
*
|
2008-07-18 |
2012-04-03 |
Abgent |
Regulation of autophagy pathway phosphorylation and uses thereof
|
|
WO2010014141A1
(en)
|
2008-08-01 |
2010-02-04 |
Lixte Biotechnology, Inc. |
Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
|
|
US9126953B2
(en)
|
2008-08-08 |
2015-09-08 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
|
EP2350118B1
(en)
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
CN104829714A
(zh)
*
|
2008-11-03 |
2015-08-12 |
阿莱斯亚生物疗法股份有限公司 |
特异性地阻滞肿瘤抗原的生物活性的抗体
|
|
WO2011054112A1
(en)
|
2009-11-03 |
2011-05-12 |
Alethia Biotherapeutics Inc. |
Antibodies that specifically block the biological activity of kidney associated antigen 1
|